| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.23 | 8e-12 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.22 | 7e-11 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.39 | 5e-09 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-09 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.29 | 2e-08 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-07 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-06 |